Xenon：癫痫助其股价至59美元；抑郁症需接力前行（纳斯达克：XENE）
· seekingalpha.com
Xenon的azetukalner三期试验将局灶性癫痫发作降低53%，FDA申报在即。点击了解更多关于XENE股票的信息。
At $59, I would not buy Xenon Pharmaceuticals Inc. (NASDAQ: XENE ) for its upcoming FDA filing. The filing is expected. The stock already carries a market value...